AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

LOPINAVIR; RITONAVIR in Zimbabwe

8 products registered with MCAZ β€” 8 active

Brand / ProductReg. No.HolderStatusExpires
LOPINAVIR; RITONAVIR
TABLET, COATED; ORAL
2014/7.13/4864HETERO LABS LTDactive24 Apr 2030
LOPINAVIR; RITONAVIR
TABLET, COATED; ORAL
2017/7.13/5353HETERO LABS LTDactive27 Feb 2030
ALLTERA 50
POWDER/SATCHETS; ORAL
2019/7.13/5894MYLAN LABORATORIES LIMITEDactive20 Nov 2028
LOPINAVIR; RITONAVIR
TABLET; ORAL
2015/7.13/5123AUROBINDO PHARMA LIMITEDactive31 Dec 2027
ALLTERA
TABLET, COATED; ORAL
2009/7.13/4566MYLAN LABORATORIES LIMITEDactive31 Dec 2027
LOPINAVIR; RITONAVIR
TABLET, COATED; ORAL
2022/7.13/6353LAURUS LABS LIMITEDactive31 Dec 2027
LOPINAVIR; RITONAVIR
TABLET, COATED; ORAL
2022/7.13/6352LAURUS LABS LIMITEDactive31 Dec 2027
LOPINAVIR; RITONAVIR
TABLET; ORAL
2015/7.13/5122AUROBINDO PHARMA LIMITEDactive31 Dec 2027

LOPINAVIR; RITONAVIR β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 8 registered products containing LOPINAVIR; RITONAVIR, of which 8 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track LOPINAVIR; RITONAVIR registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Lopinavir Ritonavir β€” Zimbabwe (MCAZ) | AfricaRegulatory